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The autoinflammatory syndromes are a group of multisys-
tem disorders characterized by recurrent episodes of fever
and systemic inflammation affecting the eyes, joints, skin,
and serosal surfaces. These syndromes differ from autoim-
mune diseases by several features, including the periodicity
whereas autoimmune diseases are progressive, and the
lack of signs of involvement of adaptive immunity such as
association with HLA aplotypes, high-titer autoantibodies
or antigen-specific T cells. Thus, autoinflammatory syn-
dromes are recognized as disorders of innate immunity.
This definition is supported by the a dramatic therapeutic
response to IL-1 blocking. Indeed, the rapid and sustained
response to a reduction in IL-1 activity on an “ex adjuvan-
tibus” basis is the best hallmark of most of these diseases.
Due to the rarity of these conditions, most of the studies
aimed to unravel the pathogenic consequences related to
the mutation of genes involved in inherited autoinflamma-
tory diseases were based on the analysis of in vitro trans-
fected cells or animal models. These approaches has the
clear advantage to facilitate the availability of material for
these studies and also to reduce the variability associated
to clinical and genetic variables (type of mutation, active
versus inactive disease, ongoing treatment, etc..). On the
other hand the use of patients’ primary cells strongly
increase the possibility that the observed phenomena
could be indeed pertinent to the pathogenesis of the dis-
ease and not influenced by possible artifacts linked to the
study of transfected cells or animal models.
In the present lecture we will review the contribution
that the study of primary cells from patients affected by
inherited autoinflammatory diseases gave to the under-
standing of the role of IL-1 in the pathogenesis of these
disorders.
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